Australian Hospital to Dose Dying Patients with Synthetic Psilocybin
St Vincent's Hospital of Melbourne, Australia will begin treating patients in April
Articles - Page 36
Aeruginascin: An Understudied Psilocybin Derivative
Seldom mentioned in scientific literature, aeruginascin is closely structurally related to psilocybin, the most well-known psychoactive compound in magic mushrooms.
Psilocybin Receives FDA Breakthrough Treatment Designation
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.
What Are Psilocybin Derivatives?
There are many compounds closely resembling psilocybin from a chemical structure standpoint. However, the chemical and pharmacological understanding of these psilocybin derivatives is few and far between.
Is Norbaeocystin an Active Component of Magic Mushrooms?
Psilocybin gets most of the attention, and other psilocybin-like compounds present in magic mushrooms have been largely ignored.
Blue Bruising: The Psilocybin Mushroom Bluing Reaction
This article explores the chemistry of blue bruising and proposes a mechanism for the chemical reaction that causes this unique effect.
The Metabolism of Psilocybin and Psilocin in Humans
The metabolism of psilocybin and psilocin is often cited. But, the supporting data are seldom discussed.
Psilocybin for Treating Phantom Pain
Psilocybin is showing promise for neuroregeneration and motor recovery in methods of treating phantom pain.
Why Don’t Magic Mushrooms Contain DMT?
Recent studies on the biosynthesis of psilocybin provide an answer to this age-old question.
Phenylethylamine: An Overlooked Active Compound in Magic Mushrooms
Magic mushrooms have multiple active components including phenethylamine. These molecules are almost never acknowledged and are probably involved the pharmacology of these fungi.